Growth Metrics

Groove Botanicals (GRVE) Common Equity (2016)

Groove Botanicals' Common Equity history spans 6 years, with the latest figure at -$921023.0 for Q4 2016.

  • For Q4 2016, Common Equity fell 149.04% year-over-year to -$921023.0; the TTM value through Dec 2016 reached -$921023.0, down 149.04%, while the annual FY2016 figure was -$598481.0, 135.41% down from the prior year.
  • Common Equity for Q4 2016 was -$921023.0 at Groove Botanicals, down from -$771663.0 in the prior quarter.
  • Across five years, Common Equity topped out at $1.9 million in Q2 2015 and bottomed at -$921023.0 in Q4 2016.
  • The 5-year median for Common Equity is $519702.0 (2012), against an average of $606723.6.
  • The largest annual shift saw Common Equity surged 139351.49% in 2015 before it crashed 149.04% in 2016.
  • A 5-year view of Common Equity shows it stood at $293445.0 in 2012, then skyrocketed by 38.97% to $407805.0 in 2013, then skyrocketed by 233.96% to $1.4 million in 2014, then skyrocketed by 37.91% to $1.9 million in 2015, then plummeted by 149.04% to -$921023.0 in 2016.
  • Per Business Quant, the three most recent readings for GRVE's Common Equity are -$921023.0 (Q4 2016), -$771663.0 (Q3 2016), and -$636213.0 (Q2 2016).